Atropine/Chlorphenamine/Pseudoephedrine

阿托品/氯苯那敏/伪麻黄碱

Report date: 2023/08/11 09:18:44

Base Information

Drug NameAtropine/Chlorphenamine/Pseudoephedrine
Drug Alias Name氯苯那敏/阿托品/伪麻黄碱Atr/CM/PSEPseudoephedrine/chlorphenamine/atropine伪麻黄碱/氯苯那敏/阿托品氯苯那敏/伪麻黄碱/阿托品 +[12
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsAlpha adrenergic receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorHistamine H1 receptorAlpha adrenergic receptor
Therapy Area/IndicationsRhinitis, Allergic, Seasonal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMagna Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMagna Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, Seasonal

Other Information

ATC CodeN/A
Related LinksN/A